key: cord-0976908-5kk04rr9
authors: Baj, Jacek; Flieger, Wojciech; Przygodzka, Dominika; Buszewicz, Grzegorz; Teresiński, Grzegorz; Pizoń, Magdalena; Maciejewski, Ryszard; Flieger, Jolanta
title: Application of HPLC-QQQ-MS/MS and New RP-HPLC-DAD System Utilizing the Chaotropic Effect for Determination of Nicotine and Its Major Metabolites Cotinine, and trans-3′-Hydroxycotinine in Human Plasma Samples
date: 2022-01-20
journal: Molecules
DOI: 10.3390/molecules27030682
sha: 6f5206b3d28f547bf293c28a3dd54fbc3e3e5e8c
doc_id: 976908
cord_uid: 5kk04rr9

The routine techniques currently applied for the determination of nicotine and its major metabolites, cotinine, and trans-3′-hydroxycotinine, in biological fluids, include spectrophotometric, immunoassays, and chromatographic techniques. The aim of this study was to develop, and compare two new chromatographic methods high-performance liquid chromatography coupled to triple quadrupole mass spectrometry (HPLC-QQQ-MS/MS), and RP-HPLC enriched with chaotropic additives, which would allow reliable confirmation of tobacco smoke exposure in toxicological and epidemiological studies. The concentrations of analytes were determined in human plasma as the sample matrix. The methods were compared in terms of the linearity, accuracy, repeatability, detection and quantification limits (LOD and LOQ), and recovery. The obtained validation parameters met the ICH requirements for both proposed procedures. However, the limits of detection (LOD) were much better for HPLC-QQQ-MS/MS (0.07 ng mL(−1) for trans-3′-hydroxcotinine; 0.02 ng mL(−1) for cotinine; 0.04 ng mL(−1) for nicotine) in comparison to the RP-HPLC-DAD enriched with chaotropic additives (1.47 ng mL(−1) for trans-3′-hydroxcotinine; 1.59 ng mL(−1) for cotinine; 1.50 ng mL(−1) for nicotine). The extraction efficiency (%) was concentration-dependent and ranged between 96.66% and 99.39% for RP-HPLC-DAD and 76.8% to 96.4% for HPLC-QQQ-MS/MS. The usefulness of the elaborated analytical methods was checked on the example of the analysis of a blood sample taken from a tobacco smoker. The nicotine, cotinine, and trans-3′-hydroxycotinine contents in the smoker’s plasma quantified by the RP-HPLC-DAD method differed from the values measured by the HPLC-QQQ-MS/MS. However, the relative errors of measurements were smaller than 10% (6.80%, 6.72%, 2.04% respectively).

Nicotine is a pyridine chiral alkaloid, most abundant in tobacco leaves (Nicotiana tabacum L.), and in smaller amounts in tomatoes and other plants in the Solanaceae family. Nicotine is known to be a highly addictive neurotoxin [1] . The lethal dose (LD 50 ) value for nicotine is approx. 1-1.5 mg per kg of body weight. The median LD 50 for nicotine is assumed to be 0.8 mg/kg for adults [2] . The Royal Children's Hospital Melbourne in the The current study is the first attempt to determine nicotine and its two major metabolites cotinine, and trans-3 -hydroxycotinine by the reverse-phase HPLC system, enriched with chaotropic additives. As predicted previously by Flieger [56] [57] [58] , the addition of the salts with chaotropic properties has a favorable effect on retention and ensured improved selectivity and efficiency of the reversed-phase chromatographic system towards basic analytes. Nicotine alkaloids as compounds possessing basic functional groups able to ionize require special chromatographic conditions. When they are analyzed by the use of strong acidic mobile phases, unfavorable silanol effects usually provide increase in retention together with the loss of column efficiency.

The aim of the current study is to investigate the usefulness of the classic RP-HPLC-DAD system enriched with the addition of a chaotropic salt for the quantitative determination of nicotine, cotinine, and trans-3 -hydroxycotinine in human plasma samples. The method was validated and compared to HPLC-QQQ-MS/MS as a reference. Both methods were compared in terms of the linearity, accuracy, repeatability, recovery as well as detection and quantification limits. Finally, the results of determination of examined analytes in real plasma samples of tobacco smokers were compared and statistically evaluated.

All analyzed compounds, i.e., nicotine, cotinine, and trans-3 -hydroxycotinine, contain nitrogen, which may be in protonated or unprotonated form, depending on the pH of the reaction medium. Nicotine containing a pyridine ring (pK a 2.96) and a pyrrolidine ring (pK a 8.07) [59, 60] occurs as a diprotonated cation with a charge on both of the ionizable moieties in an acidic aqueous medium. The pK a value for both cotinine and trans-3hydroxycotinine is about 4.5 also due to the protonation of nitrogen on the pyridine ring. Thus, the above analytes exist as the cationic forms in the acidic eluent system (pH 2.7). The analytes ionization is a source of strong electrostatic interactions with the counter-anion of the chaotropic salt providing the retention of analytes with distinct hydrophilic properties (log P of nicotine is 0.93, log P of cotinine is 0.07, and log P of trans-3 -hydroxycotinin equals −1.45) on a hydrophobic RP sorbent. The use of the mobile phase with pH smaller than 3, has also other advantages in the case of UV detection mode because the protonated forms possess higher absorbance at 260 nm in comparison to the ones existing at higher pH. Figure 1 presents a chromatogram of a mixture containing trans-3 -hydroxycotinine, cotinine, and nicotine obtained by the use of RP-HPLC-DAD system utilizing sodium hexafluorophosphate as a chaotropic additive to the acidic mobile phase.

cross-linked diol with gradient elution mode from 98% to 35% acetonitrile in 10 mmol L −1 of ammonium formate buffer at pH 3.0.

The current study is the first attempt to determine nicotine and its two major metabolites cotinine, and trans-3′-hydroxycotinine by the reverse-phase HPLC system, enriched with chaotropic additives. As predicted previously by Flieger [56] [57] [58] , the addition of the salts with chaotropic properties has a favorable effect on retention and ensured improved selectivity and efficiency of the reversed-phase chromatographic system towards basic analytes. Nicotine alkaloids as compounds possessing basic functional groups able to ionize require special chromatographic conditions. When they are analyzed by the use of strong acidic mobile phases, unfavorable silanol effects usually provide increase in retention together with the loss of column efficiency.

The aim of the current study is to investigate the usefulness of the classic RP-HPLC-DAD system enriched with the addition of a chaotropic salt for the quantitative determination of nicotine, cotinine, and trans-3′-hydroxycotinine in human plasma samples. The method was validated and compared to HPLC-QQQ-MS/MS as a reference. Both methods were compared in terms of the linearity, accuracy, repeatability, recovery as well as detection and quantification limits. Finally, the results of determination of examined analytes in real plasma samples of tobacco smokers were compared and statistically evaluated.

All analyzed compounds, i.e., nicotine, cotinine, and trans-3′-hydroxycotinine, contain nitrogen, which may be in protonated or unprotonated form, depending on the pH of the reaction medium. Nicotine containing a pyridine ring (pKa 2.96) and a pyrrolidine ring (pKa 8.07) [59, 60] occurs as a diprotonated cation with a charge on both of the ionizable moieties in an acidic aqueous medium. The pKa value for both cotinine and trans-3′-hydroxycotinine is about 4.5 also due to the protonation of nitrogen on the pyridine ring. Thus, the above analytes exist as the cationic forms in the acidic eluent system (pH 2.7). The analytes ionization is a source of strong electrostatic interactions with the counter-anion of the chaotropic salt providing the retention of analytes with distinct hydrophilic properties (log P of nicotine is 0.93, log P of cotinine is 0.07, and log P of trans-3′-hydroxycotinin equals -1.45) on a hydrophobic RP sorbent. The use of the mobile phase with pH smaller than 3, has also other advantages in the case of UV detection mode because the protonated forms possess higher absorbance at 260 nm in comparison to the ones existing at higher pH. Figure 1 presents a chromatogram of a mixture containing trans-3′-hydroxycotinine, cotinine, and nicotine obtained by the use of RP-HPLC-DAD system utilizing sodium hexafluorophosphate as a chaotropic additive to the acidic mobile phase. The analysis was performed using an Agilent 5 HC-C18(2) (250 × 4.6 mm I.D.) column. The mobile phase was acetonitrile (10%, v/v), 20 mM phosphate buffer pH = 2.7 containing 30 mM NaPF 6 in the whole mobile phase. The DAD detection was set at 260 nm.

As it can be seen, the applied eluent system permitted complete resolution of the analyzed compounds in an analysis time lower than 15 min. The chaotropic additive ensured satisfactory efficiency expressed in the theoretical plates number (N) in the range of 27,960 to 62,440, and peak symmetry (As) no more than 1.5 at each case. According to spectra collected for examined compounds (Figure 2 ) in the range from 220 nm to 400 nm, the detection wavelength was established at 260 nm. Further optimization experiments were performed at the chosen analytical wavelength. Figure 1 . HPLC-DAD chromatogram obtained for solution of standards: trans-3′-hydroxycotinine (tr = 4.63 min), cotinine (tr = 6.16 min), nicotine (tr = 11.01 min) at the concentration level of 500 ng L −1 . The analysis was performed using an Agilent 5 HC-C18(2) (250 × 4.6 mm I.D.) column. The mobile phase was acetonitrile (10%, v/v), 20 mM phosphate buffer pH = 2.7 containing 30 mM NaPF6 in the whole mobile phase. The DAD detection was set at 260 nm.

As it can be seen, the applied eluent system permitted complete resolution of the analyzed compounds in an analysis time lower than 15 min. The chaotropic additive ensured satisfactory efficiency expressed in the theoretical plates number (N) in the range of 27,960 to 62,440, and peak symmetry (As) no more than 1.5 at each case. According to spectra collected for examined compounds (Figure 2 ) in the range from 220 nm to 400 nm, the detection wavelength was established at 260 nm. Further optimization experiments were performed at the chosen analytical wavelength. In the case of quantitative analysis, a very important aspect is to achieve the low limits of detection (LOD). A significant reduction in the LOD value can be obtained thanks to the preparation of samples in the mobile phase ( Figure 3 ). As a result, it was possible to reduce the LOD value for nicotine 3.6 times from 6.86 to LOD = 1.89 ng mL −1 . The LOD value for cotinine decreased from 3.88 to 1.77 ng mL −1 . The best result was obtained for trans-3′-hydroxycotinine, for which the LOD value was reduced 7.6 times from 11.7 to 1.53 ng mL −1 . As can be seen, chaotropic additive provided a higher signal level as well as significantly reduced unwanted noise. Therefore, samples for further quantification were prepared by dilution with the mobile phase. In the case of quantitative analysis, a very important aspect is to achieve the low limits of detection (LOD). A significant reduction in the LOD value can be obtained thanks to the preparation of samples in the mobile phase ( Figure 3 ). As a result, it was possible to reduce the LOD value for nicotine 3.6 times from 6.86 to LOD = 1.89 ng mL −1 . The LOD value for cotinine decreased from 3.88 to 1.77 ng mL −1 . The best result was obtained for trans-3 -hydroxycotinine, for which the LOD value was reduced 7.6 times from 11.7 to 1.53 ng mL −1 . As can be seen, chaotropic additive provided a higher signal level as well as significantly reduced unwanted noise. Therefore, samples for further quantification were prepared by dilution with the mobile phase. , cotinine (tr = 6.16 min), nicotine (tr = 11.01 min) at the concentration level of 500 ng L −1 . The analysis was performed using an Agilent 5 HC-C18(2) (250 × 4.6 mm I.D.) column. The mobile phase was acetonitrile (10%, v/v), 20 mM phosphate buffer pH = 2.7 containing 30 mM NaPF6 in the whole mobile phase. The DAD detection was set at 260 nm.

As it can be seen, the applied eluent system permitted complete resolution of the analyzed compounds in an analysis time lower than 15 min. The chaotropic additive ensured satisfactory efficiency expressed in the theoretical plates number (N) in the range of 27,960 to 62,440, and peak symmetry (As) no more than 1.5 at each case. According to spectra collected for examined compounds (Figure 2 ) in the range from 220 nm to 400 nm, the detection wavelength was established at 260 nm. Further optimization experiments were performed at the chosen analytical wavelength. In the case of quantitative analysis, a very important aspect is to achieve the low limits of detection (LOD). A significant reduction in the LOD value can be obtained thanks to the preparation of samples in the mobile phase ( Figure 3 ). As a result, it was possible to reduce the LOD value for nicotine 3.6 times from 6.86 to LOD = 1.89 ng mL −1 . The LOD value for cotinine decreased from 3.88 to 1.77 ng mL −1 . The best result was obtained for trans-3′-hydroxycotinine, for which the LOD value was reduced 7.6 times from 11.7 to 1.53 ng mL −1 . As can be seen, chaotropic additive provided a higher signal level as well as significantly reduced unwanted noise. Therefore, samples for further quantification were prepared by dilution with the mobile phase. were estimated considering the analyte concentration that produces a chromatographic peak having a height equal to three times the standard deviation of the baseline noise.

The matrix effect usually comes from endogenous components coming from the sample or contaminants introduced in the pretreatment process. The matrix effect can be evaluated as the ratio between the slopes of the linear calibration equations of analyte dissolved in the blank matrix per that one obtained for analyte dissolved in the organic solvent. In DAD detection mode, the investigated analytes cotinine, nicotine, and trans-3hydroxycotinine demonstrated a relatively strong matrix effect equaling 86.58%, 94.55%, and 83.42% respectively. In the aim to avoid the influence of the matrix on analytes quantification, the standard addition method (fortification method) ensuring the stability and accuracy of the results was applied in subsequent experiments.

Linearity, LOD and LOQ values were determined for all analytes using an artificial plasma matrix that was spiked with the analytes at seven different concentration levels. The obtained mixtures were further analyzed by the extraction procedure described in the Section 4.2.2. The calibration curves were linear in the range from 10 to 1200 ng mL −1 with the determination coefficients (R 2 ) being greater than 0.9980. The least-squares linear regression analysis was used to determine the statistic parameters which were collected in Table 1 . For recovery and repeatability examination blank plasma matrix was spiked with mixed standard solutions on three concentration levels. Each level was quantified six times to calculate the recovery and relative standard deviation (RSD). Inter-and intra-day precision and accuracy data for nicotine and its metabolites were determined with the LQC (100 ng mL −1 ), MQC (500 ng mL −1 ), and HQC (1000 ng mL −1 ) samples. Figure 4 presents a representative chromatogram of blank artificial plasma sample and plasma spiked with trans-3 -hydroxycotinine, cotinine, and nicotine on different concentration levels.

The analytes concentration was calculated from the calibration curve. Recovery (%) was calculated by comparing the measured analyte concentration to the expected value. Intra-day data were assessed by comparing data from within one run (n = 3 for each QC). Inter-day validation data were obtained from analyses conducted on three subsequent days (n = 3). Accuracy was in the range of 96.66% to 99.39%. Coefficients of variation (CVs) were <5% for intraday precision and <6% for interday precision. Obtained results summarized in Table 2 were considered acceptable for all quality samples considering criteria established by the US FDA, that is 85-115% for accuracy, and ±15% for precision [61, 62] . The matrix effect usually comes from endogenous components coming from the sample or contaminants introduced in the pretreatment process. The matrix effect can be evaluated as the ratio between the slopes of the linear calibration equations of analyte dissolved in the blank matrix per that one obtained for analyte dissolved in the organic solvent. In DAD detection mode, the investigated analytes cotinine, nicotine, and trans-3′-hydroxycotinine demonstrated a relatively strong matrix effect equaling 86.58%, 94.55%, and 83.42% respectively. In the aim to avoid the influence of the matrix on analytes quantification, the standard addition method (fortification method) ensuring the stability and accuracy of the results was applied in subsequent experiments.

Linearity, LOD and LOQ values were determined for all analytes using an artificial plasma matrix that was spiked with the analytes at seven different concentration levels. The obtained mixtures were further analyzed by the extraction procedure described in the Subsection 4.2.2. The calibration curves were linear in the range from 10 to 1200 ng mL −1 with the determination coefficients (R 2 ) being greater than 0.9980. The least-squares linear regression analysis was used to determine the statistic parameters which were collected in Table 1 . For recovery and repeatability examination blank plasma matrix was spiked with mixed standard solutions on three concentration levels. Each level was quantified six times to calculate the recovery and relative standard deviation (RSD). Inter-and intra-day precision and accuracy data for nicotine and its metabolites were determined with the LQC (100 ng mL −1 ), MQC (500 ng mL −1 ), and HQC (1000 ng mL −1 ) samples. The analytes concentration was calculated from the calibration curve. Recovery (%) was calculated by comparing the measured analyte concentration to the expected value. Intra-day data were assessed by comparing data from within one run (n = 3 for each QC). Inter-day validation data were obtained from analyses conducted on three subsequent days (n = 3). Accuracy was in the range of 96.66% to 99.39%. Coefficients of variation (CVs) were <5% for intraday precision and <6% for interday precision. Obtained results summarized in Table 2 were considered acceptable for all quality samples considering criteria established by the US FDA, that is 85-115% for accuracy, and ±15% for precision [61, 62] . The standard additions calibration method was used to determine the concentration of the investigated analytes in a real human plasma sample coming from the tobacco smoker. This method is commonly found when working with clinical, biological, or food samples mainly to avoid the matrix effect and unexpected interferences from matrix components. In a smoker's plasma sample, nicotine and its metabolites were expected at rather low concentration levels. To avoid loss of precision as a result of sample dilution, 

The standard additions calibration method was used to determine the concentration of the investigated analytes in a real human plasma sample coming from the tobacco smoker. This method is commonly found when working with clinical, biological, or food samples mainly to avoid the matrix effect and unexpected interferences from matrix components. In a smoker's plasma sample, nicotine and its metabolites were expected at rather low concentration levels. To avoid loss of precision as a result of sample dilution, the supernatant obtained after mixing plasma with an organic solvent was lyophilized and dissolved in a small volume of 300 µL of the mobile phase. Obtained results were collected in Table 3 . 

When standards and deuterated internal standards were added to the blank plasma sample, all analytes showed clear well-defined peaks without any interferences. The intensities of the peaks were above 200-times higher in comparison to the background signals detected for the blank plasma samples ( Figure 5 ). HPLC-QQQ-MS/MS chromatograms of nicotine and examined metabolites are collected in Figure 6 . 

When standards and deuterated internal standards were added to the blank plasma sample, all analytes showed clear well-defined peaks without any interferences. The intensities of the peaks were above 200-times higher in comparison to the background signals detected for the blank plasma samples ( Figure 5 ). HPLC-QQQ-MS/MS chromatograms of nicotine and examined metabolites are collected in Figure 6 . 

Nicotine and its metabolites calibration curves were prepared in the range 2.0 to 200 ng mL −1 . Calibration curve parameters were collected in Table 4 . For each of the compounds tested, the curves had an R 2 above 0.999 (only for nicotine it was 0.9989). Smoker's plasma samples were analyzed together with two QC samples (20 and 200 ng mL −1 ). The recovery study was performed for each analyte at two concentration levels of 20 and 200 ng mL −1 . As can be seen in Table 5 , the recovery of analytes was concentration-dependent. For the smaller concentration of 20 ng mL −1 the percentage of recovery was in the range from 76.8% to 81.9%, whereas for ten times higher concentration levels, 

Nicotine and its metabolites calibration curves were prepared in the range 2.0 to 200 ng mL −1 . Calibration curve parameters were collected in Table 4 . For each of the compounds tested, the curves had an R 2 above 0.999 (only for nicotine it was 0.9989).

Smoker's plasma samples were analyzed together with two QC samples (20 and 200 ng mL −1 ). The recovery study was performed for each analyte at two concentration levels of 20 and 200 ng mL −1 . As can be seen in Table 5 , the recovery of analytes was concentrationdependent. For the smaller concentration of 20 ng mL −1 the percentage of recovery was in the range from 76.8% to 81.9%, whereas for ten times higher concentration levels, the 

The nicotine, cotinine, and trans-3 -hydroxycotinine contents in the smoker's plasma quantified by the RP-HPLC-DAD method differ from the values measured by the HPLC-QQQ-MS/MS. The relative error values were 6.80%, 6.72%, 2.04%, respectively. It should be noted, however, that the marked quantities are of the same order of magnitude. To statistically compare the series of measurements, linear regression analysis or a Bland-Altman plot (B & A is known as the Tukey mean difference plot) could be used. It could be possible in the case of much more samples from smokers. Unfortunately, blood collection is an invasive procedure, so in the future, the applicability of the method should be checked on other biological matrices, such as urine or saliva. The results were compared utilizing a statistical significance t-test. The results obtained for analysis of trans-3 -hydroxycotinine, cotinine and nicotine in plasma samples using HPLC-DAD and HPLC-QQQ-MS/MS showed that there are no significant differences between these two chromatographic techniques using the t-test at a significance level of 0.05 on a two-tailed test for 2 degrees of freedom.

The presence of nicotine metabolites in body fluids can be confirmed by various techniques, differing in implementation costs, time consumption, selectivity, reliability and efficiency. Despite the availability of a wide range of analytical tools, the most technologically advanced ones are not standard laboratory equipment, and their operation is too expensive to be used for epidemiological, toxicological and even clinical screening, which prefer quick and cheap analytical techniques.

Our study concerns a new method for the determination of nicotine, cotinine and trans-3 -hydroxycotinin in the blood plasma, using the classic RP-HPLC-DAD system modified with the addition of NaPF 6 chaotropic salt at millimolar concentration. The obtained results regarding the selectivity of the separation exceed the previous HPLC separations, which have been described in the literature so far. The addition of a chaotropic salt had a positive effect on the achieved detection and quantification limits. It is known, however, that HPLC-DAD cannot compete with tandem mass spectrometry, which allows for unique identification of compounds and provides the best possible sensitivity of the method. It should be emphasized, that the obtained limit of quantification (LLOQ) for cotinine was even smaller than 10 ng mL −1 . This value is sufficient for selecting smokers, because according to Kim [63] the serum cotinine cutoff value range of 10-20 ng/mL, serving as a cut-off point to verify patients according to their tobacco status.

Our study confirmed the advantage of chaotropic additives in RP systems over gradient analysis or multi-component eluents in order to ensure appropriate selectivity and sensitivity. Comparing the new RP-HPLC method with the previous ones, there is a noticeable difference in the achieved limits of detection and quantification. In the developed method, the detection limit for nicotine, cotinine and trans-3 -hydroxycotinin is 1.50 ng mL −1 , 1.59 ng mL −1 and 1.47 ng mL −1 , respectively. Using HPLC-QQQ-MS/MS, the LOD values were even more spectacular achieving the levels of 0.04, 0.02, 0.07 ng mL −1 respectively. Miller et al. [38] reported a similar detection limit of 1 ng/mL for all analytes for LC-MS/MS with electrospray ionization (ESI) using multiple reaction monitoring (MRM). Whereas McGuffey et al. [40] reported the detection limits of 1.94, 1.55, 3.53 ng/mL for trans-3 -hydroxycotinine, nicotine, cotinine respectively in LC-MS/MS measurements. Usually, the limit of quantification achieved by LC-MS/MS are smaller like 0.36, 0.32 ng/mL for nicotine, cotinine, respectively [45] . Zuccaro et al. [21] described the HPLC-DAD method that provided the limit of detection for nicotine, cotinine and trans-3 -hydroxycotinin of 10, 5, and 5 ng mL −1 , respectively. The method used a time-consuming gradient elution, which allowed the separation of the analytes in more than 20 min. Another advantage of our method is the possibility of isocratic elution in no more than 15 min. While most authors using MS detection, despite its exceptional sensitivity, use the gradient elution mode [26] [27] [28] [29] [30] 33, 34, 38, 40, 46, 47] . Until now, only a few papers reported the usefulness of the isocratic elution mode [25, 37, 39] .

The high convergence of the results (the relative error <10%) obtained with the new method and the reference one in the test carried out on a tobacco smoker, as well as the satisfactory validation parameters prove the success of the new method in confirming and quantifying the exposure to nicotine and its metabolites. The new method can be an alternative tool in applications that prefer fast, cheap, reliable methods using standard laboratory equipment.

Standards of (−)-nicotine, (−)-cotinine, trans-3 -hydroxcotinine, caffeine were purchased from Sigma-Aldrich (St. Louis, MO, US). Deuterated (±)-nicotine-d4, and (±)cotinine-d3 standards were purchased from Merck (Darmstadt, Germany). Sodium hexafluorophosphate (NaPF 6 ), ammonium formate (HCOONH 4 ) eluent additive for LC-MS, LiChropur ™ , ≥99.0%, formic acid (HCOOH) 98-100% for LC-MS LiChropur ™ were obtained from Sigma-Aldrich. 85% m/m phosphoric acid (H 3 PO 4 ), and sodium hydroxide (NaOH) were obtained from POCH (Gliwice, Poland). Plasma Control was obtained from Recipe chemicals (München, Germany). Acetonitrile (ACN, C 2 H 3 N) and methanol (MeOH, CH 3 OH) of HPLC reagent grade were obtained from Merck (Darmstadt, Germany). Water purified by ULTRAPURE Millipore Direct-Q 3UV-R (Merck, Darmstadt, Germany) of the resistivity 18.2 MΩ cm was used to prepare the aqueous solutions.

The HPLC analysis was carried out using Elite LaChrom HPLC Merck-Hitachi (Merck, Darmstadt, Germany), equipped with a DAD detector (L-2455), column thermostat Jetstream 2 Plus (100,375, Knauer). Chromatographic separation was conducted at 30 • C on a reversed-phase column Agilent 5 HC-C18(2) (250 × 4.6 mm I.D., 5 µm, 180 A, Agilent Technologies, Santa Clara, CA, US). The mobile phase composed of 10% (v/v) acetonitrile in phosphate buffer was pumped through the chromatographic system at a flow rate of 1.0 mL min −1 . The buffer concentration was 20 mM, whereas chaotropic salt concentration was 30 mM in the whole mobile phase. The initial buffer solution (0.1 M) was prepared by dissolving 0.5 mL 85% (m/m) orthophosphoric acid in 80 mL water and adjusting to pH = 2.7 with saturated sodium hydroxide solution. The pH values were measured with CPC-105 Elmetron pH-meter (Zabrze, Poland). The mobile phases were filtered with a Nylon 66 membrane filter (Merck, Darmstadt, Germany) with pore size 0.45 µm. The injection volume was 20 µL corresponding to the volume of the Rheodyne injector loop. The diode array detector was operated at 260 nm.

Individual stock solutions of nicotine and its metabolites were prepared in methanol and stored at −20 • C. The calibration curve standards of each analyte at seven concentration levels in the range of 10.00 to 1200.00 ng mL −1 (10, 50, 200 , 400, 700, 900, 1200 ng L −1 ) were prepared by serial dilution of the 20 µg mL −1 stock solutions with the mobile phase. Working solutions were prepared also for quality control samples (QCs) by dilutions of stock solution to obtain a final concentration of 100, 500, 1000 ng L −1 .

The calibration curves were constructed by plotting the standard peak area versus the concentrations spiked in the blank artificial plasma matrix. A total 0.01 mL of artificial plasma matrix, which was free from nicotine metabolites were spiked with 0.05 mL of the appropriate standard solution. Then, 140 µL acetonitrile was added to each mixture, vortex 60 s and centrifuged at 9000× g for 30 min. The supernatant of each aliquot of plasma was diluted to 1 mL with the mobile phase. A 20 µL of the extract was injected directly into the HPLC column. The statistical parameters of the curve were estimated using linear regression analysis. The LOD and LOQ were derived via signal-to-noise ratio (SN). The LOQ is 10 times the standard deviation (σ) of the blank whereas the LOD is related to 3σ. Recoveries and stability were examined using blank samples fortified with three different levels of 100, 500, and 1000 ng L −1 . Samples of each level were prepared in six replicates. The relative standard deviation (RSD) values represent the variability and repeatability of the method.

Human plasma samples were collected by venipuncture (approximately 10 mL of whole blood) from a healthy volunteer who gave informed consent, 15 min after smoking the cigarette. The sample was immediately centrifuged at 870 g for 10 min to obtain plasma. The plasma from the smoker was analyzed maintaining the fixed plasma to acetonitrile ratio (1:14). To 1.45 mL of plasma, 20 mL of acetonitrile was added, then vortex 10 min and centrifuged at 9000× g for 30 min. The obtained supernatant was lyophilized with freeze dryer Christ ALPHA 2-4 LD plus from Millrock Technology (Kingston, NY, USA), and the dry residue was dissolved in 300 µL of the mobile phase. The solution was divided into five vials, each with 50 µL. Then the samples were spiked with the same volume (50 µL) of the mixture containing increasing concentration of the analytes giving finally concentration of 10, 50, 100, 300, and 500 ng mL −1 . The samples of 20 µL were injected directly into the HPLC column. The calibration curves of this new data set showed linear relationships between the analyte concentrations versus the peak areas measured at 260 nm of wavelength. The concentration of the analyte was determined by extrapolating the line to the x-axis of the calibration curve. The final results were calculated considering the dilution (2×) and concentrating steps (4.83×).

The LC-MS analysis was carried out using a triple quadrupole system (HPLC 1260 Agilent Technologies, Germany coupled to triple quadrupole mass spectrometer QqQ 6460, Agilent Technologies, USA) equipped with electron spray ionization (ESI) source. The chromatographic separations were performed using a ZORBAX RRHD StableBond C18 column 2.1 × 150 mm, 1.8 µm, (Agilent Technologies, USA). The column was heated to 50 • C. The analytes were eluted using a mobile phase consisting of 40% (v/v) acetonitrile in 5 mM ammonium formate (pH 4.5) in water pumped at a flow-rate of 300 µL min −1 . The injection volume was 2 µL. The run time for HPLC-MS/MS method was 3.5 min. Mass spectrometric data were collected in positive ion mode, using multiple reaction monitoring mode. The ESI-MS/MS parameters and the retention time for the tested compounds are presented in Table 6 . Calibration curve was prepared using plasma without nicotine and its metabolites. To 45 µL of clear plasma was added 5 µL of methanol solution of nicotine and its metabolites in proper concentration (to obtain levels 2, 5, 10, 20, 100 and 200 ng mL −1 ). Then was added 5 µL of deuterated internal standards (IS), i.e., nicotine-D4 and cotinine-D3 at a concentration of 100 ng mL −1 in MeOH. Samples were precipitated with 500 µL of frozen acetonitrile containing 0.1% HCOOH. The sample was centrifuged 2 min at 14,000 rpm, then the 500 µL supernatant was transferred to an Eppendorf vial (2 mL). It was evaporated to dryness under a stream of N 2 at 40 • C (using a RapidVap ® N 2 /48 rotary evaporator, Labconco, Kansas City, MO, USA). The dry residue was dissolved in 50 µL of the eluent and centrifuged for 2 min (at 14,000 rpm). The extracts were transferred to the inserts and analyzed with the HPLC-QQQ-MS/MS system.

Quantitative analysis was performed using a calibration curve in the range of 2-200 ng mL −1 . In order to validate the method, six replications were performed for each of the calculated parameters (repeatability and recovery) at two concentration levels. Determination of LODs (limits of detection) and LOQs (limit of quantification) was based on the calibration curve. The LOD values were calculated as 3 × σ/S where S is the slope of the calibration curve and σ is the standard deviation of the response, while the LOQ was calculated as 10 × σ/S.

A total 50 µL of test plasma and 5 µL of deuterated internal standards (IS), i.e., nicotine-D4 and cotinine-D3 at a concentration of 100 ng mL −1 in MeOH, were added to a 2 mL test tube. Plasma with IS supplement was mixed and precipitated by adding 500 µL of frozen acetonitrile containing 0.1% HCOOH. The sample was centrifuged for 2 min at 14,000 rpm, then the 500 µL supernatant was transferred to an Eppendorf vial (2 mL). It was evaporated to dryness under a stream of N 2 at 40 • C (using a RapidVap ® N 2 /48 rotary evaporator). The dry residue was dissolved in 50 µL of the eluent and centrifuged for 2 min (at 14,000 rpm). The extracts were transferred to the inserts and analyzed with the HPLC-QQQ-MS/MS system.

The paper compares two methods used for the determination of nicotine and its metabolites in human blood plasma, i.e., HPLC-QQQ-MS/MS and RP-HPLC-DAD enriched with the addition of chaotropic salt. Both methods met the validation criteria for the determination of xenobiotics in biological matrices regarding linearity, accuracy, repeatability, detection, and quantification limits. It should be emphasized that our work presents, for the first time, a reversed-phase HPLC chromatographic system enriched with chaotropic additives, for this purpose. RP-HPLC-DAD belongs to classic techniques, which are widely applied in analytical laboratories. We have proven that it can be easily adapted to study nicotine metabolites. Despite, the quantification limits of the HPLC-QQQ-MS/MS method being characterized by several times lower values, the developed chaotropic RP-HPLC-DAD method appears to be sufficient for toxicological and epidemiological studies of selecting patients exposed to tobacco smoke.

Neuroprotective and neurotoxic effects of nicotine

How much nicotine kills a human? Tracing back the generally accepted lethal dose to dubious self-experiments in the nineteenth century

The Chemical Components of Tobacco and Tobacco Smoke

Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control

Implementing Smoke-Free Environments; World Health Organization

Addressing New and Emerging Products; World Health Organization

Pharmacology of nicotine: Addiction, smoking-induced disease, and therapeutics

Nicotine chemistry, metabolism, kinetics and biomarkers

Metabolism and disposition kinetics of nicotine

Nicotine, its metabolism and an overview of its biological effects

Pharmacogenetics of nicotine and associated smoking behaviors

Cotinine as a biomarker of environmental tobacco smoke exposure

Serum cotinine as a marker of environmental tobacco smoke exposure in epidemiological studies: The experience of the MATISS project

Characterization of multiple products of cytochrome P450 2A6-catalyzed cotinine metabolism

Levels of the Thiocyanate in the Saliva of Tobacco Smokers in Comparison to e-Cigarette Smokers and Nonsmokers Measured by HPLC on a Phosphatidylcholine Column

Analysis for nicotine and cotinine in hair to determine cigarette smoker status

Quantification of cotinine in plasma and saliva by liquid chromatography

Cotinine in the serum, saliva, and urine of nonsmokers, passive smokers, and active smokers

A sensitive enzyme immunoassay for measuring cotinine in passive smokers

Determination of nicotine and four metabolites in the serum of smokers by high-performance liquid chromatography with ultraviolet detection

Simultaneous determination of nicotine and cotinine in serum using high-performance liquid chromatography with fluorometric detection and postcolumn UV-photoirradiation system

Determination of Nicotine-Related Impurities in Nicotine Pouches and Tobacco-Containing Products by Liquid Chromatography-Tandem Mass Spectrometry

Simultaneous determination of nicotine, cotinine, and nicotine N-oxide in human plasma, semen, and sperm by LC-Orbitrap MS

Determination of nicotine and cotinine in human serum by means of LC/MS

Determination of the nicotine metabolites cotinine and trans-3 -hydroxycotinine in biologic fluids of smokers and non-smokers using liquid chromatography-tandem mass spectrometry: Biomarkers for tobacco smoke exposure and for phenotyping cytochrome P450 2A6 activity

A liquid chromatography-mass spectrometry method for nicotine and cotinine; utility in screening tobacco exposure in patients taking amiodarone

Optimization and validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of nicotine, cotinine, trans-3 -hydroxycotinine and norcotinine in human oral fluid

Quantification of nicotine, cotinine, trans-3 -hydroxycotinine and varenicline in human plasma by a sensitive and specific UPLC-tandem mass-spectrometry procedure for a clinical study on smoking cessation

Simultaneous quantification of nicotine, cotinine, trans-3 -hydroxycotinine, norcotinine and mecamylamine in human urine by liquid chromatography-tandem mass spectrometry

GC-MS determined cotinine in an epidemiological study on smoking status at delivery

Simple, rapid and sensitive assay method for simultaneous quantification of urinary nicotine and cotinine using gas chromatography-mass spectrometry

Quantitation of nicotine, its metabolites, and other related alkaloids in urine, serum, and plasma using LC-MS-MS

Simultaneous and sensitive measurement of anabasine, nicotine, and nicotine metabolites in human urine by liquid chromatography-tandem mass spectrometry

Quantitation of the Minor Tobacco Alkaloids Nornicotine, Anatabine, and Anabasine in Smokers' Urine by High Throughput Liquid Chromatography-Mass Spectrometry

A Comparison of Direct and Indirect Analytical Approaches to Measuring Total Nicotine Equivalents in Urine

Quantification of Nicotine and Cotinine in Plasma, Saliva, and Urine by HPLC Method in Chewing Tobacco Users. Asian Pac

A novel validated procedure for the determination of nicotine, eight nicotine metabolites and two minor tobacco alkaloids in human plasma or urine by solid-phase extraction coupled with liquid chromatography-electrospray ionization-tandem mass spectrometry

Simultaneous determination of nicotine and eight nicotine metabolites in urine of smokers using liquid chromatography-tandem mass spectrometry

Validation of a LC-MS/MS method for quantifying urinary nicotine, six nicotine metabolites and the minor tobacco alkaloids-Anatabine and anabasine-In smokers' urine

Determination of nicotine and nicotine metabolites in urine by hydrophilic interaction chromatographytandem mass spectrometry: Potential use of smokeless tobacco products by ice hockey players

Determination of nicotine, cotinine, and related alkaloids in human urine and saliva by automated in-tube solid-phase microextraction coupled with liquid chromatography-mass spectrometry

Validation and application of a method for the determination of nicotine and five major metabolites in smokers' urine by solid-phase extraction and liquid chromatography-tandem mass spectrometry

A high-throughput robotic sample preparation system and HPLC-MS/MS for measuring urinary anatabine, anabasine, nicotine and major nicotine metabolites

A simple, fast, and sensitive method for the measurement of serum nicotine, cotinine, and nornicotine by LC-MS/MS

Simultaneous serum nicotine, cotinine, and trans-3 -hydroxycotinine quantitation with minimal sample volume for tobacco exposure status of solid organ transplant patients

A rapid LC-MS-MS method for the determination of nicotine and cotinine in serum and saliva samples from smokers: Validation and comparison with a radioimmunoassay method

A fully validated LC-MS/MS method for simultaneous determination of nicotine and its metabolite cotinine in human serum and its application to a pharmacokinetic study after using nicotine transdermal delivery systems with standard heat application in adult smokers

Hair nicotine/cotinine concentrations as a method of monitoring exposure to tobacco smoke among infants and adults

Validation of a liquid chromatography-tandem mass spectrometry method for the detection of nicotine biomarkers in hair and an evaluation of wash procedures for removal of environmental nicotine

Analysis of Nicotine Metabolites in Hair and Nails Using QuEChERS Method Followed by Liquid Chromatography-Tandem Mass Spectrometry

Analysis of nicotine and cotinine in hair by on-line in-tube solid-phase microextraction coupled with liquid chromatography-tandem mass spectrometry as biomarkers of exposure to tobacco smoke

Hair analysis of nicotine and cotinine for evaluating tobacco smoke exposure by liquid chromatography-mass spectrometry

Rapid and High Throughput Measurement of Nicotine in Human Serum by Automation and Liquid Chromatography-Atmospheric Pressure Ionization Tandem Mass Spectrometry

Sensitive Quantification of Nicotine in Bronchoalveolar Lavage Fluid by Acetone Precipitation Combined with Isotope-Dilution Liquid Chromatography-Tandem Mass Spectrometry

The effect of chaotropic mobile phase additives on the separation of selected alkaloids in reversed-phase highperformance liquid chromatography

Comparison of chaotropic salt and ionic liquid as mobile phase additives in reversed-phase high-performance liquid chromatography of biogenic amines

Usefulness of chaotropic salt additive in RP-HPLC of organic nonionized compounds

Spectroscopic investigations into the acid-base properties of nicotine at different temperatures

Biomarkers of Tobacco Smoke Exposure

Key elements of bioanalytical method validation for small molecules

Quantitative bioanalytical methods validation and implementation: Best practices for chromatographic and ligand binding assays

Overview of Cotinine Cutoff Values for Smoking Status Classification

Written informed consent has been obtained from the patient(s) to publish this paper.

The data presented in this study are available upon request from Jolanta Flieger.

The authors declare no conflict of interest.